Usage of Dapagliflozin in the Management of Type-2 Diabetes Mellitus: A Real World Evidence Study in Indian Patients
Clinical trial NCT03071016 · COMPLETED
Trial details
- NCT number
- NCT03071016
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-03-04
- Primary completion
- 2018-03-03
- Enrollment
- 2000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.